Volatility Recedes

Headlines say market volatility recedes as investors brush off Trump’s tariff threats and all stock picks this week are 77% BUY, 10% HOLD and 13% SELL.

1. BUY Shell

Top performing stock pick this week is BUY Shell by Simon Watkins in The Motley Fool with a tip performance of 3%.

Shell is a British multinational oil and gas company, headquartered in London. Shell is a public limited company with a primary listing on the London Stock Exchange and secondary listings on Euronext Amsterdam and the New York Stock Exchange. Founded in 1907, by 1920 Shell was the largest producer of oil in the world.

Shell share price launched at 1,196p in 1996, rose to an all-time high of 2,937p in 2024 and is today at 2,660p.

In the news this week as the Libyan civil war comes to an end, signalling opportunities for oil & gas companies to reenter the jurisdiction. Shell has signed an agreement with Libya’s National Oil Corporation (NOC) to develop the ‘Al-Ashtan’ field and others, which are currently controlled by NOC.

In Stockomendation five analysts: Berenberg and Simon Watkins with BUY, Morgan Stanley with HOLD, Citi is NEUTRAL and Russ Mould says HOLD. One open fund manager short position, view that here.

2. BUY Celebrus

Second top performing stock pick this week is BUY Celebrus Technologies by Canaccord Genuity with a tip performance of 3%.

Celebrus Technologies (formerly D4t4 Solutions Plc) provides a data technology platform focused on improving relationships between brands and consumers through data.

Celebrus Technologies share price launched at 27p in 1997, rose to an all-time high of 390p in 2021 and is today at 171p.

On 8th July the company issued a company update in this RNS announcing two customer wins. Canaccord Genuity upgraded its rating to BUY and set a new target price of 295p.

In Stockomendation four analysts: Canaccord Genuity and Zaven Boyrazian with BUY, Dr. James Fox with ADD and Steve Moore with AVOID. There are no active short positions.

3. HOLD GSK

Third top performing stock pick is HOLD GSK by Deutsche Bank with a tip performance of 3%.

GSK is a British multinational pharmaceutical and biotechnology company headquartered in London. Founded in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, it is the tenth largest pharmaceutical company.

GSK share price launched at 346p in 1989, rose to an all-time high of 2,046p in 1998 and is now at 1,457p.

On Wednesday Deutsche Bank reaffirmed its hold rating on the company and set a price target of 1,450p.

In Stockomendation four analysts: Simon Watkins with BUY, Deutsche Bank and Berenberg with HOLD and Goldman Sachs is NEUTRAL. There are two open fund manager short positions, view those here.

Join Now

Think you can pick stocks? Play the July league UK Share Picking game FREE : uksharepickinggame.co.uk

Disclaimer: The contents of this article should not be considered financial advice. Pricing data correct as at 11th July 2025.